- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05152108
Hybrid Brain Computer Interface for Control of Sensory - Motor Coupling in Post - Stroke Rehabilitation (HYBIS)
December 4, 2024 updated by: Konstantinovic Ljubica, University of Belgrade
Feasibility Clinical Study of a Novel Hybrid Brain Computer Interface for Control of Sensory-motor Coupling in Post-stroke Rehabilitation
HYBIS project aims to develop an innovative and unique hybrid Brain-Computer Interface (BCI) system.
This BCI system is envisioned as a novel tool for targeted reinforcement of sensory motor coupling, specifically dedicated for upper-limb post-stroke rehabilitation.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Belgrade, Serbia, 11000
- Clinic for rehabilitation dr Miroslav Zotovic Faculty of Medicine University of Belgrade
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- age over 18 years old at the time of enrolment
- history of cerebrovascular insult verified by computerized tomography or magnetic resonance imaging;
- stoke occurred not more than 6 months prior to study enrolment;
- subject need to be medically and neurologically stable determined by medical history and documented neurological examination;
- ability to understand, communicate and cooperate with the research team;
- ability to sit for at least 45 minutes and the ability to adhere to the study rehabilitation protocol.
Exclusion Criteria:
- any neurologic condition (beyond the stroke) or physical condition that impaired function of the affected arm
- a substantial cardiopulmonary or metabolic disorder or other major medical complication;
- history of seizures;
- moderate to severe hemispatial neglect or anosognosia involving the affected arm;
- severe sensory deficit;
- inability to understand, cooperate, and adhere to the study procedures;
- severe spasticity defined as Ashworth scale score of 4 in the affected arm;
- contraindication to stimulation system placement;
- nursing a child;
- pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stroke patients
Experimental group of stroke survivors for testing the feasibility of a BCI system
|
Testing the feasibility of BCI device by determining the accuracy of BCI control
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Electrotactile BCI system accuracy
Time Frame: within 30 minutes after experimental session
|
Electrotactile BCI system accuracy is a measure of feasibility of the prototype device.
Accuracy [0 -100 %] of classification of user's mental strategy (tactile attention task towards one of the two electrical stimulation hotspots), where higher values of accuracy are related to better system control.
|
within 30 minutes after experimental session
|
|
Motor Imagery BCI system accuracy
Time Frame: within 30 minutes after experimental session
|
Motor Imagery BCI system accuracy is a measure of feasibility of the prototype device. Accuracy [0 - 100 %] of classification between rest and imaginary movement in a cue-based manner, , where higher values of accuracy are related to better system control. |
within 30 minutes after experimental session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fugl Meyer sensory score for upper extremity
Time Frame: immediately after experimental session
|
Fugl Meyer sensory score for upper extremity assesses the degree of sensory impairment in the upper arm.
Sensation score ranges from 0 to 12 points, divided into 4 points for light touch and 12 points for position sense.
Individual items pertaining to the light touch sensation of the upper arm/ forearm and palmary surface of the hand and to the position of the shoulder/ elbow/ wrist/ thumb (IP-joint) are scored on a 3-point ordinal scale and summed for a maximum possible score of 12.
The higher score is considered to represent a less sensory deficit of the subject
|
immediately after experimental session
|
|
NASA-TLX
Time Frame: within 30 minutes after experimental session
|
NASA Task Load Index (NASA-TLX) method assesses workload on six scales for different aspects: mental demand, physical demand, temporal demand, performance, effort, and frustration on a 21-point scale.
A higher rating represents higher workload.
|
within 30 minutes after experimental session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2022
Primary Completion (Estimated)
July 15, 2025
Study Completion (Estimated)
December 15, 2025
Study Registration Dates
First Submitted
November 13, 2021
First Submitted That Met QC Criteria
November 26, 2021
First Posted (Actual)
December 9, 2021
Study Record Updates
Last Update Posted (Estimated)
December 9, 2024
Last Update Submitted That Met QC Criteria
December 4, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6066223
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
Clinical Trials on BCI feasibility test
-
Biotheranostics, Inc.Active, not recruiting
-
University of SheffieldNot yet recruitingMild Cognitive Impairment (MCI)United Kingdom
-
Oregon Health and Science UniversityCompletedAmyotrophic Lateral Sclerosis | Muscular Dystrophies | Spinal Cord Injuries | Multiple System Atrophy | Parkinson's Disease and Parkinsonism | Brain Tumor Adult | Locked-in Syndrome | Brainstem StrokeUnited States
-
Massachusetts General HospitalBrainCells Inc.CompletedMajor Depressive DisorderUnited States
-
US Department of Veterans AffairsNew York State Department of HealthCompletedALS (Amyotrophic Lateral Sclerosis)United States
-
University Hospital, GrenobleFrench Alternative Energies and Atomic Energy Commission (CEA), GrenobleNot yet recruiting
-
Shanghai Zhongshan HospitalNot yet recruitingTetraplegic Motor Dysfunction Following Brainstem or Spinal Cord InjuryChina
-
National University Hospital, SingaporeNational University Health System, Singapore; Agency for Science, Technology...Completed
-
BrainCells Inc.CompletedAnxiety | Major Depressive DisorderCanada
-
Institute of Mental Health, SingaporeDuke-NUS Graduate Medical School; Agency for Science, Technology and ResearchCompletedEmotion RegulationSingapore